Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TASDA trial of non-antibiotic outpatient treatment for acute uncomplicated diverticulitis
2016-001812-39Phase 4Active
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Aug 2017
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofloxacin and amoxicillin in acute diverticulitis (AD) (2 arms), sponsored by Vall d'Hebron University Hospital. Primary endpoint: Treatment failure. Started Aug 2017; status: active.
02
Drugs
ciprofloxacinamoxicillin
03
Conditions
acute diverticulitis (AD)
Beyond the preview
Go deeper on 2016-001812-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001812-39.